InvestorsHub Logo
Followers 28
Posts 4346
Boards Moderated 1
Alias Born 09/22/2006

Re: None

Tuesday, 02/28/2023 2:32:04 PM

Tuesday, February 28, 2023 2:32:04 PM

Post# of 8570
BMY's Opdivo might be approved for Melanoma this year. They are partnering with HALO on a different indication, but it might redound to Halozyme's benefit in the near term.
https://finance.yahoo.com/news/u-food-drug-administration-accepts-115900042.html

The more you know, the less you don't know.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News